ArticleBMC pharmacology & toxicology2014

Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells.

Jianchu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.